Clinical application of liquid biopsy genomic profiling in NSCLC: Asian perspectives-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical application of liquid biopsy genomic profiling in NSCLC: Asian perspectives

Published:2024-03 Issue: Volume:3 Page:100131
ISSN:2950-1954
Container-title:The Journal of Liquid Biopsy
language:en
Short-container-title:The Journal of Liquid Biopsy

Author:

Li Molly S.C.^ORCID,Mok Kevin K.S.,Chan Landon L.,Mok Tony S.K.

Publisher

Elsevier BV

Reference111 articles.

1. The effect of advances in lung-cancer treatment on population mortality;Howlader;N Engl J Med,2020

2. Dynamic changes of Health utility in lung cancer patients receiving different treatments: a 7-year follow-up;Yang;J Thorac Oncol,2019

3. Developments in targeted therapy & immunotherapy—how non-small cell lung cancer management will change in the next decade: a narrative review;Li;Ann Transl Med,2023

4. Liquid biopsy for advanced NSCLC: a consensus statement from the international association for the study of lung cancer;Rolfo;J Thorac Oncol,2021

5. Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3